Scholarly Index
James J. Harding
Memorial Sloan Kettering Cancer Center; 16,860 total citations; 298 total publications; best world rank #42
Memorial Sloan Kettering Cancer Center
16,860Total citations
298Total publications
50H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 563 | US 166 | 97.86 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 853 | US 223 | 97.60 |
| Cancer Mechanisms and Therapy | Lifetime | 391 | US 177 | 96.06 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 42 | US 12 | 98.90 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 146 | US 53 | 98.50 |
| Peptidase Inhibition and Analysis | 2021-2025 | 220 | US 65 | 95.24 |
| Cancer Genomics and Diagnostics | 2021-2025 | 851 | US 368 | 95.05 |
| Gallbladder and Bile Duct Disorders | 2021-2025 | 654 | US 129 | 90.65 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 936 | US 161 | 91.40 |
| Cancer Mechanisms and Therapy | 2021-2025 | 541 | US 72 | 79.13 |
| Fibroblast Growth Factor Research | 2021-2025 | 264 | US 83 | 77.41 |
| Biochemical and Molecular Research | 2021-2025 | 710 | US 146 | 66.42 |